Baseline total metabolic tumor volume assessed by 18FDG-PET/CT predicts outcome in advanced melanoma patients treated with pembrolizumab

Gil Awada, Ibrahim Özdemir, Julia Katharina Schwarze, Emma Daeninck, Odrade Gondry, Yanina Jansen, Teofila Caplanusi, Marleen Keyaerts, Hendrik Everaert, Bart Neyns

Research output: Contribution to journal › Meeting abstract (Journal)

68 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Baseline total metabolic tumor volume assessed by 18FDG-PET/CT predicts outcome in advanced melanoma patients treated with pembrolizumab'. Together they form a unique fingerprint.

Medicine & Life Sciences